Axogen, Inc. (AXGN): Operating Cash Flow
$812.0K
Year ended 2025-12-31
$15.05M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $812.0K | -82.1% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $4.54M | n/m | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | -$5.72M | n/m | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | -$16.07M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$13.40M | n/m | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | -$9.63M | n/m | 2023-03-14, From 2020-01-01 |
| 2019-12-31 | -$19.87M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$17.86M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$9.24M | n/m | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | -$11.24M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$13.05M | n/a | 2018-02-28, From 2015-01-01 |
| No annual figure between 2012-12-31 and 2015-12-31. | |||
| 2012-12-31 | -$8.66M | n/m | 2013-08-07, From 2012-01-01 |
| 2011-12-31 | -$7.08M | n/m | 2013-08-07, From 2011-01-01 |
| 2010-12-31 | -$3.94M | n/a | 2012-03-15, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Axogen, Inc. (AXGN) | 2025-12-31 | $812.0K | -82.1% |
| InMode Ltd. (INMD) | 2025-12-31 | $85.26M | -35.7% |
| Outset Medical, Inc. (OM) | 2025-12-31 | -$46.33M | n/m |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $20.11M | +138.6% |
| Vaso Corp (VASO) | 2025-12-31 | $9.27M | +182.6% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | -$40.81M | n/m |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $192.84M | +295.1% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $9.66M | -15.2% |
| Iridex Corp (IRIX) | 2026-01-03 | -$2.12M | n/m |
Compare AXGN, INMD, OM, BLFS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗